Literature DB >> 15335224

New treatments for agitation.

Leslie Citrome1.   

Abstract

Acute agitation is a frequent reason for emergency psychiatric intervention. It is important to intervene early to avoid escalation of agitation to aggression. Reducing risk by using effective treatments will result in fewer instances of seclusion and restraint, and fewer injuries to staff and patients. This paper will first review the epidemiology of aggressive behavior and mental disorders, followed by a discussion of assessment and diagnostic considerations. The pathophysiology of safety risk is discussed within the context of the model of the "triune brain." Pharmacological treatment strategies for acute episodes of agitated behavior will be discussed in detail. This includes newer formulations of novel antipsychotics such as liquids and rapidly disintegrating tablets, as well as intramuscular preparations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15335224     DOI: 10.1023/b:psaq.0000031791.53142.85

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  42 in total

Review 1.  Acute psychopharmacological management of the aggressive psychotic patient.

Authors:  D H Hughes
Journal:  Psychiatr Serv       Date:  1999-09       Impact factor: 3.084

2.  Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.

Authors:  P Wright; M Birkett; S R David; K Meehan; I Ferchland; K J Alaka; J C Saunders; J Krueger; P Bradley; L San; M Bernardo; M Reinstein; A Breier
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

3.  The triune brain in conflict.

Authors:  P D MacLean
Journal:  Psychother Psychosom       Date:  1977       Impact factor: 17.659

4.  Three cases of akathisia and "acting out".

Authors:  S G Siris
Journal:  J Clin Psychiatry       Date:  1985-09       Impact factor: 4.384

5.  Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.

Authors:  J Battaglia; S Moss; J Rush; J Kang; R Mendoza; L Leedom; W Dubin; C McGlynn; L Goodman
Journal:  Am J Emerg Med       Date:  1997-07       Impact factor: 2.469

6.  Repetitively violent patients in psychiatric units.

Authors:  C Owen; C Tarantello; M Jones; C Tennant
Journal:  Psychiatr Serv       Date:  1998-11       Impact factor: 3.084

7.  A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.

Authors:  Padraig Wright; Karena Meehan; Martin Birkett; Stacy R Lindborg; Cindy C Taylor; Philip Morris; Alan Breier
Journal:  Clin Ther       Date:  2003-05       Impact factor: 3.393

8.  Haloperidol for sedation of disruptive emergency patients.

Authors:  J E Clinton; S Sterner; Z Stelmachers; E Ruiz
Journal:  Ann Emerg Med       Date:  1987-03       Impact factor: 5.721

9.  Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.

Authors:  Glenn W Currier; James C-Y Chou; David Feifel; Cynthia A Bossie; Ibrahim Turkoz; Ramy A Mahmoud; Georges M Gharabawi
Journal:  J Clin Psychiatry       Date:  2004-03       Impact factor: 4.384

Review 10.  A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients.

Authors:  John H Shale; Christopher M Shale; William D Mastin
Journal:  J Clin Psychiatry       Date:  2003-05       Impact factor: 4.384

View more
  3 in total

1.  Professionals' attitudes toward reducing restraint: the case of seclusion in the Netherlands.

Authors:  Marjan van Doeselaar; Peter Sleegers; Giel Hutschemaekers
Journal:  Psychiatr Q       Date:  2008-01-03

Review 2.  The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.

Authors:  Konstantinos N Fountoulakis; Allan Young; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Pierre Blier; Hans Jurgen Moeller; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

3.  Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach.

Authors:  Leonardo Baldaçara; Alexandre P Diaz; Verônica Leite; Lucas A Pereira; Roberto M Dos Santos; Vicente de P Gomes Júnior; Elie L B Calfat; Flávia Ismael; Cintia A M Périco; Deisy M Porto; Carlos E K Zacharias; Quirino Cordeiro; Antônio Geraldo da Silva; Teng C Tung
Journal:  Braz J Psychiatry       Date:  2019-03-07       Impact factor: 2.697

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.